Avoro Capital Advisors LLC Takes Position in Mind Medicine (MindMed) Inc. $MNMD

Avoro Capital Advisors LLC acquired a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 5,000,000 shares of the company’s stock, valued at approximately $66,950,000. Mind Medicine (MindMed) comprises about 0.7% of Avoro Capital Advisors LLC’s holdings, making the stock its 22nd biggest holding.

Other large investors also recently made changes to their positions in the company. ExodusPoint Capital Management LP acquired a new stake in shares of Mind Medicine (MindMed) in the 4th quarter valued at approximately $254,000. Marex Group plc acquired a new stake in shares of Mind Medicine (MindMed) in the 4th quarter valued at approximately $268,000. EntryPoint Capital LLC acquired a new stake in shares of Mind Medicine (MindMed) in the 4th quarter valued at approximately $271,000. Concurrent Investment Advisors LLC acquired a new stake in shares of Mind Medicine (MindMed) in the 4th quarter valued at approximately $273,000. Finally, PSP Research LLC acquired a new stake in shares of Mind Medicine (MindMed) in the 4th quarter valued at approximately $467,000.

Mind Medicine (MindMed) Price Performance

NASDAQ MNMD opened at $0.69 on Wednesday. The firm has a 50 day moving average price of $0.69.

Mind Medicine (MindMed) (NASDAQ: MNMD) is a clinical-stage biotechnology company focused on developing psychedelic-inspired medicines and accompanying therapeutic protocols to treat mental health disorders and substance use disorders. The company’s research emphasizes both novel small molecules and established psychedelic compounds used in controlled, clinically supervised settings, with the goal of creating safe, scalable treatments that combine pharmacology with psychotherapy.

MindMed’s activities include preclinical research, clinical trials, and the development of treatment delivery models and protocols that integrate drug administration with therapeutic support.